Today, Benzinga's options scanner spotted 14 options trades for CRISPR Therapeutics. This is not a typical pattern. The sentiment among these major traders is split, with 28% bullish and 42% bearish.
Scientists have discovered a way to make gene editing safer and more precise — and it's an advance that could help bolster ...
The clinical success of CRISPR-based treatments is fundamentally dependent on sophisticated gRNA targeting systems that ...
New data from Spherix Global Insights uncover how hematologists are defining the “right patient” for gene therapy, balancing promise with practical barriers in sickle cell disease, thalassemia, and ...
REPAIRome specifically addresses the repair of one of the most serious types of DNA damage, DNA double-strand breaks (DSBs).
Is kidney xenotransplantation an answer to the kidney organ shortage? Experts weigh in the current promise and potential medical hurdles.
Schulich prof Dr. Robert Hegele inducted into Canadian Medical Hall of Fame in recognition of his lipid disorder research to reduce heart attacks, strokes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback